The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Lipid Risk factors and Atherosclerosis: What do We Measure?
Abstract
Coronary atherosclerotic disease remains the major cause of mortality and morbidity in western societies. Despite significant reductions in the incidence of death associated with the disorder over the last 30 years, especially in the United States, there is an urgent need to identify more clearly the underlying causative agents so that primary and secondary prevention programs can be implemented. A number of lipid parameters such as total and LDL-cholesterol have withstood long-term evaluation, and have met all the criteria necessary to designate them as playing a causative role in coronary atherosclerosis. These two parameters, especially LDL-cholesterol, is now the focus of a number of public health initiatives in various countries. The role of HDL-cholesterol is still not yet certain, while that of triglycerides is still clouded. A host of newer lipid associated (apolipoprotein) parameters are currently under investigation and it will be a number of years before any of these could be designated in the same class as LDL-cholesterol. Among the apolipoprotein measurements, Apo B appears to be the most promising in terms of meeting requirements to elevate it from risk factor to causative agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
Cited by
Vegetables, Fruit, and Cancer Prevention
STEINMETZ, K. A., & POTTER, J. D. (1996) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(96)00273-8 · Cited by 2,118
Phyto-oestrogens and Western Diseases
Adlercreutz, H., & Mazur, W. (1997) · Annals of Medicine · doi:10.3109/07853899709113696 · Cited by 1,279
Dietary agents in cancer prevention: flavonoids and isoflavonoids
Birt, D. F., Hendrich, S., & Wang, W. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00137-1 · Cited by 1,171
Vegetables, fruit, and cancer. II. Mechanisms
Steinmetz, K. A., & Potter, J. D. (1991) · Cancer Causes and Control · doi:10.1007/bf00054304 · Cited by 804
Adlercreutz, H. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00777-5 · Cited by 661
Metadata
- Authors
- Stein, E. A.
- Venue
- Scandinavian Journal of Clinical and Laboratory Investigation
- Publisher
- Informa UK Limited
- Published
- 1990-01
- Volume
- 50
- Issue
- sup198
- Pages
- 3-8
- ISSN
- 0036-5513 (ISSN-L)
- 1502-7686
- OpenAlex
- W2000190402
- Cited by
- 214
- References
- 3
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lipid Risk factors and Atherosclerosis: What do We Measure? https://app.cochat.ai/papers/10.1080/00365519009091078
- The paper
- Stein, E. A. (1990). Lipid Risk factors and Atherosclerosis: What do We Measure? Scandinavian Journal of Clinical and Laboratory Investigation. https://doi.org/10.1080/00365519009091078
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.